Dear Friends! Do you wish to witness the ground-shaking and revolutionary inventions in the area of clinical trial management? Innovations that make clinical performance control, fraud detection, data integrity, and risk evaluation easy and effective? Design your own cockpit of a clinical trial together with us and [...]
01.04.2016. Cyntegrity, cloud solution service provider for the efficient Risk-based Monitoring (RBM) of a clinical trial, is pleased to announce its partnership with Metrics Champion Consortium (MCC). MCC is the thought leader in providing metrics for the clinical trials industry offering qualitative and quantitative [...]
In the nearest week-end Cyntegrity migrates all its Risk-based Monitoring services to one unified address: RBM.Cloud. The CRO oversight services will be later migrated to: CRO.Cloud.
The free @RACT platform, which is used already by many companies, e.g., the first 50 users from big-pharma and CRO (e.g. Daiichi Sankyo, Merz, PPD, MedPace, INC Research etc.), was today updated with the new version 2.0. Besides hundreds of smaller improvements, there are 6 [...]
Dear Partners and Customers, Cyntegrity wishes you merry holidays, successful new year and new interesting projects together! We wish you to have all your risks under control! Yours Cyntegrity!
Cyntegrity has updated the SandBox environment with the Version 3.5 of the RBM solution EarlyBird. The most informative & understandable graphs, robust KRIs, clear performance indicators will turn your experience with RBM analytics to a real adventure! Test it yourself. Free. [...]
Meet Cyntegrity on French EPharma Day in Paris, which is dedicated to European Regulation and Data Transparency. On Wednesday, 25 November 2015, Cyntegrity will present "How to Master the new EU Regulation with Risk-based Monitoring (RBM)". The presentation will demonstrate that risk management is much wider [...]
On 17 - 19 November 2015 Artem Andrianov, CEO of Cyntegrity, shares experience and case studies at Partnership in Clinical Trials in Hamburg during a PCT RBM workshop. The topic of the workshop will be dedicated to most burning RBM questions today like: - What KRIs and [...]
by Artem Andrianov, PhD, Beat Widler, PhD, Maria Proupín-Pérez, PhD Originally published by Applied Clinical Trials Online Available: http://www.appliedclinicaltrialsonline.com/ich-gcp-goes-risk-based.
Going Public Biotechnology Magazine p.76-77 The new upcoming GCP E6(R2) addendum reforms clinical monitoring and clinical trial management. Risk factors are an important component. What this means for a biotech company: clinical trial risks are easy to foresee, site level risks and operational risks [...]
